Amosartan ranks the top in the KRW 150 billion improved drug market for 4 years

Published: 2015-09-23 15:29:54

Updated: 2015-09-23 15:29:54

Hanmi Pharm’s Amosartan Tab 5/50mg has kept the top position in the improved drug market for 4 consecutive years.

DailyPharm analyzed actual outputs of the top 18 improved drugs for the past 4 years.

Last year, the Big 5 improved drugs were Amosartan 5/50mg(KRW 39.7 billion), Amosartan 5/100mg(KRW 28.9 billion), Pletaal SR Cap(Korea Otsuka Pharmaceuticals, KRW 12.8 billion), Risenex Plus Tab(...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.